Maria Grazia Narducci Selected Research

Sezary Syndrome (Sezary Erythroderma)

1/2022	Continuous low-dose gemcitabine in primary cutaneous T cell lymphoma: A retrospective study.
1/2020	Reduction of T Lymphoma Cells and Immunological Invigoration in a Patient Concurrently Affected by Melanoma and Sezary Syndrome Treated With Nivolumab.
1/2020	Preclinical Evidence for Targeting PI3K/mTOR Signaling with Dual-Inhibitors as a Therapeutic Strategy against Cutaneous T-Cell Lymphoma.
11/2010	The role of 9-O-acetylated ganglioside D3 (CD60) and {alpha}4{beta}1 (CD49d) expression in predicting the survival of patients with Sezary syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maria Grazia Narducci Research Topics

Disease

6	Lymphoma (Lymphomas) 11/2022 - 01/2018
6	Neoplasms (Cancer) 01/2022 - 02/2006
4	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2022 - 09/2008
4	Sezary Syndrome (Sezary Erythroderma) 01/2022 - 11/2010
3	Mycosis Fungoides 01/2022 - 11/2010
2	T-Cell Lymphoma (Lymphoma, T Cell) 01/2020 - 02/2006
2	T-Cell Leukemia (Leukemia, T Cell) 01/2020 - 01/2018
1	Melanoma (Melanoma, Malignant) 01/2020
1	Exfoliative Dermatitis (Erythroderma) 01/2012
1	B-Cell Lymphoma (Lymphoma, B Cell) 11/2010
1	Eczema 11/2010
1	Disease Progression 09/2008

Drug/Important Bio-Agent (IBA)

2	Biomarkers (Surrogate Marker)IBA 01/2020 - 02/2019
2	ChemokinesIBA 09/2008 - 02/2006
1	Interleukin-2 (IL2)IBA 11/2022
1	Adenosine Triphosphate (ATP)IBA 11/2022
1	Gemcitabine FDA Link 01/2022
1	TOR Serine-Threonine KinasesIBA 01/2020
1	Biological ProductsIBA 01/2020
1	EnzymesIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2020
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2020
1	NivolumabIBA 01/2020
1	Insulin-Like PeptidesIBA 01/2018
1	Interleukin-5 (Interleukin 5)IBA 01/2012
1	Interleukin-4 (Interleukin 4)IBA 01/2012
1	GangliosidesIBA 11/2010
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2010
1	NF-kappa B (NF-kB)IBA 11/2009
1	TNF Receptor-Associated Factor 2 (TRAF2)IBA 11/2009

Therapy/Procedure

3	Therapeutics 06/2022 - 01/2020
1	Immunotherapy 11/2022
1	Cell Transplantation 01/2022